A Phase 3, Multinational, Long-Term Follow-Up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical study
Clinical Trial Grant
Administered By
Pediatrics, Pulmonary and Sleep Medicine
Awarded By
Sarepta Therapeutics, Inc.
Start Date
March 21, 2024
End Date
April 1, 2031
Administered By
Pediatrics, Pulmonary and Sleep Medicine
Awarded By
Sarepta Therapeutics, Inc.
Start Date
March 21, 2024
End Date
April 1, 2031